AD/PD 2021: Roche's monoclonal antibody targeting Alpha-Synuclein, Prasinezumab, may ...

Retrieved on: 2021-03-16 12:48:16

Tags for this article:

Click the tags to see associated articles and topics

AD/PD 2021: Roche's monoclonal antibody targeting Alpha-Synuclein, Prasinezumab, may .... View article details on hiswai:

Excerpt

Roche presented its monoclonal antibody (mAb)-targeting alpha (α)-synuclein, prasinezumab, for the treatment of Parkinson's disease at the 15th ...

Article found on: www.pharmaceutical-technology.com